Ichor Holdings - Ordinary Shares (ICHR)
Live price chart, market sentiment, and community perspectives for Ichor Holdings (NASDAQ: ICHR).
Live price chart, market sentiment, and community perspectives for Ichor Holdings (NASDAQ: ICHR).
On our desk, the recent price action following the Q2 2026 print has been nothing short of fascinating. Generating $294.8 million in revenue—up 15% sequentially—shows that the semiconductor capital equipment recovery is filtering down nicely into fluid delivery subsystems. However, looking at the valuation framework, we are staying somewhat cautious. While non-GAAP EPS came in solid at $0.34, the GAAP net income was a modest $998 thousand, and operating cash flow burned nearly $18.8 million in the first half due to surging inventory needs. We want to see cash conversion stabilize before expanding our long exposure.
Reviewing the risk checklist for ICHR, there are clear flags that require close monitoring. Notably, CEO Philip Ryan Barros executed a sale of 13,705 shares following an option exercise, netting roughly $962,000, which contributes to a broader pattern of significant insider selling over the past three months. Coupled with the completion of a $200 million at-the-market equity offering that expanded the share supply, prospective investors must weigh these dilution and distribution signals against the undeniably strong top-line guidance and an improved cash position of $256 million.
From a technical and fundamental modeling perspective, when underwriting Ichor Holdings right now, you have to reconcile the divergence between GAAP and non-GAAP performance metrics. For Q2 2026, the company posted a GAAP EPS of just $0.03 compared to a non-GAAP EPS of $0.34. When testing your thesis during deep-dives, ensure your operational models account for why the first half saw negative operating cash flows despite robust revenue growth—primarily driven by higher receivables and inventory build-up to meet rebounding customer demand in the semiconductor space.
Explore plasma cleansing, somatic organ swaps, and BCI.